People: Stericycle, Inc. (SRCL.O)
SRCL.O on Nasdaq
51.06USD
11:21am EST
51.06USD
11:21am EST
Price Change (% chg)
$-0.49 (-0.95%)
$-0.49 (-0.95%)
Prev Close
$51.55
$51.55
Open
$50.98
$50.98
Day's High
$51.75
$51.75
Day's Low
$50.88
$50.88
Volume
92,158
92,158
Avg. Vol
840,126
840,126
52-wk High
$58.34
$58.34
52-wk Low
$44.36
$44.36
Summary
| Name | Age | Since | Current Position |
|---|---|---|---|
| Miller, Mark | 53 | 2008 | Chairman of the Board, President, Chief Executive Officer |
| Ten Brink, Frank | 52 | 1997 | Chief Financial Officer, Executive Vice President - Finance |
| Collins, Michael | 52 | 2006 | President - Return Management Services |
| Kogler, Richard | 49 | 2000 | Chief Operating Officer, Executive Vice President |
| Foss, Richard | 54 | 2008 | Executive Vice President - International |
| Marasco, Richard | 52 | 2008 | Executive Vice President - Mergers & Acquisision |
| Schuler, Jack | 68 | 2008 | Lead Director |
| Dammeyer, Rod | 68 | 1998 | Director |
| Patience, John | 61 | 1989 | Director |
| Lord, Jonathan | 54 | 2004 | Director |
| Hall, William | 65 | 2006 | Director |
| Spaeth, Ronald | 65 | 2008 | Director |
| Brown, Thomas | 60 | 2008 | Director |
| Reid-Anderson, James | 50 | 2009 | Director |
Biographies
| Name | Description |
|---|---|
| Miller, Mark | Mark C. Miller is Chairman of the Board of Directors, President and Chief Executive Officer of Stericycle Inc. He has served as President and Chief Executive Officer and a director of the Company since joining in May 1992 and became Chairman of the Board of Directors in August 2008. From May 1989 until he joined Stericycle Inc., Mr. Miller served as vice president for the Pacific, Asia and Africa in the international division of Abbott Laboratories, a diversified health care company, which he joined in 1976 and where he held a number of management and marketing positions. Mr. Miller received a B.S. degree in computer science from Purdue University, where he graduated Phi Beta Kappa. |
| Ten Brink, Frank | Frank J.M. Ten Brink has served as the Executive Vice President, Finance and Chief Financial Officer of Stericycle, Inc. since June 1997. From 1991 until 1996 he served as chief financial officer of Hexacomb Corporation, and from 1996 until joining Stericycle, Inc., he served as chief financial officer of Telular Corporation. Prior to 1991, he held various financial management positions with Interlake Corporation and Continental Bank of Illinois. Mr. Ten Brink received a B.B.A. degree in international business and a M.B.A. degree in finance from the University of Oregon. |
| Collins, Michael | Michael J. Collins has served as President of the Return Management Services Division of Stericycle, Inc. since June 2006. Prior to joining Stericycle, Inc., he served at Abbott Laboratories, a diversified health care company, which he joined in 1982 and where he held a number of management and marketing positions, most recently as vice president, medical products group health systems. Mr. Collins received a B.A. degree in business and education from the University of New Haven and a M.B.A. degree in business administration from National University. |
| Kogler, Richard | Richard T. Kogler is Chief Operating Officer, Executive Vice President of Stericycle, Inc. He joined Stericycle, Inc. as Chief Operating Officer in December 1998. From May 1995 through October 1998, Mr. Kogler was vice president and chief operating officer of American Disposal Services, Inc., a solid waste management company. From October 1984 through May 1995, Mr. Kogler served in a variety of management positions with Waste Management, Inc. Mr. Kogler received a B.A. degree in chemistry from St. Louis University. |
| Foss, Richard | Richard L. Foss has been Executive Vice President - International of Stericycle Inc, since July 2008. Mr. Foss has served as Executive Vice President of Corporate Development since March 2003. Mr. Foss comes to Stericycle with a broad base of Healthcare and Marketing experience. He was most recently the Corporate Vice President and Director of Worldwide Product Marketing at Motorola. Prior to joining Motorola, he held progressively responsible marketing positions in Procter & Gamble including Vice President and General Manager of US Oral Care Products, and General Manager U.S. Respiratory and Gastrointestinal Products. Mr. Foss received his B.S. in Chemistry and M.B.A from Rensselaer Polytechnic Institute. |
| Marasco, Richard | Richard J. Marasco has been Executive Vice President, Mergers and Acquisitions of Stericycle Inc. Marasco served as Corporate Vice President, Mergers & Acquisitions upon joining the company in September 2007 and became Executive Vice President, Mergers & Acquisitions in July 2008. Prior to joining the company, he served at Abbott Laboratories, which he joined in 1981 and where he served in various management positions, most recently as Vice President, Europe and Canada and Vice President Pediatric Nutrition with Ross Products. He holds a B.S. degree in accounting from Drake University and is a licensed certified public accountant. |
| Schuler, Jack | Jack W. Schuler serves as the lead Director of Board of Directors and served as the Chairman of the Board of Stericycle Inc. from January 1990 until becoming lead director in August 2008. From January 1987 to August 1989, Mr. Schuler served as president and chief operating officer of Abbott Laboratories, a diversified health care company, where he served as a director from April 1985 to August 1989. Mr. Schuler serves as a director of Medtronic, Inc., a medical technology company, and Quidel Corporation, a developer and manufacturer of point-of-care diagnostic tests. He is a co-founder of Crabtree Partners LLC, a private investment firm in Lake Forest, Illinois, which was formed in June 1995. Mr. Schuler received a B.S. degree in mechanical engineering from Tufts University and a M.B.A. degree from the Stanford University Graduate School of Business Administration. |
| Dammeyer, Rod | Rod F. Dammeyer has served as a Director of Stericycle Inc. since January 1998. He is the President of CAC, LLC, a private company providing capital investment and management advisory services, and is the retired vice chairman of Anixter International, where he served from 1985 until February 2001, and retired managing partner of corporate investments of Equity Group Investments, L.L.C., where he served from 1995 until June 2000. Mr. Dammeyer serves as a director of Quidel Corporation, a developer and manufacturer of point-of-care diagnostic tests, and also serves as a trustee of Van Kampen Investments, Inc. He received a B.S. degree from Kent State University. |
| Patience, John | John Patience has served as a Director of Stericycle Inc. since incorporation in March 1989. He is a co-founder and partner of Crabtree Partners LLC, a private investment firm in Lake Forest, Illinois, which was formed in June 1995. From January 1988 to March 1995, Mr. Patience was a general partner of a venture capital firm that he co-founded which led Company's initial capitalization. He received B.A. and LL.B. degrees from the University of Sydney in Sydney, Australia, and a M.B.A. degree from the Wharton School of Business of the University of Pennsylvania. |
| Lord, Jonathan | Dr. Jonathan T. Lord, M.D. has served as a Director of Stericycle Inc. since August 2004. Dr. Lord is President and Chief Executive Officer of Navigenics, a leader in personalized genetic testing focused on prevention and wellness. Dr. Lord had been Humana’s chief innovation officer and led the development of new products and services to fundamentally transform the healthcare system and support personal health needs. Dr. Lord also led Humana’s international efforts as Chief Executive of Humana Europe. Before Humana, Dr. Lord was president of Health Dialog in Boston, where he helped pioneer e-enabled health care and promoted shared decision making between doctors and patients. He previously served as chief operating officer of the American Hospital Association in Washington, D.C., executive vice president of Anne Arundel Medical Center in Annapolis, M.D., and executive vice president of Sun Health in Charlotte, NC. Dr. Lord is a board-certified forensic pathologist with more than three decades of experience in medical practice and leadership. He launched his medical career with the U.S. Navy, where he spent 11 years on active duty and served in leadership positions for the Navy’s Surgeon General and Secretary of the Navy. He currently serves on the Advisory Board to the Director of the CDC, the National Biosurveillance Committee, and the World Economic Forum’s Global Agenda Council on Chronic Disease and Malnutrition. He is also a director for Dexcom (DXCM). He received his medical degree from the University of Miami in 1978. |
| Hall, William | William K. Hall has served as a Director of Stericycle Inc., since August 2006. He is a private equity investor who has served since 2000 as chairman of the board and chief executive officer of Procyon Technologies, Inc., a privately-owned holding company. From 1994 to 2000, Mr. Hall was chairman and chief executive officer of Falcon Building Products, Inc., a manufacturer and distributor of construction products. He currently serves on the boards of Actuant Corporation, a diversified industrial products manufacturer, A. M. Castle & Co., a specialty metals and plastics distributor, Great Plains Energy Incorporated, a diversified energy producer, and W.W. Grainger, a supplier of facilities maintenance products. Mr. Hall received a B.S.E. degree in aeronautical engineering, a M.S. degree in mathematical statistics, and M.B.A. and Ph.D. degrees in business from the University of Michigan. |
| Spaeth, Ronald | Ronald G. Spaeth has served as a Director of Stericycle Inc. since May 2008. Mr. Spaeth served as president of Evanston Northwestern Healthcare Foundation from 2002 to 2007 and as the president and chief executive officer of Highland Park (Illinois) Hospital from 1983 to 2002. He is a director of Cole Taylor Bank and also serves as a director of several private companies. Mr. Spaeth is a member of the board of commissioners of the Joint Commission on the Accreditation of Healthcare Organizations and was formerly a member of the board of trustees of the American Hospital Association, chairman of the board of trustees of the Illinois Hospital Association and chairman of the board of governors of the American College of Healthcare Executives. He received a B.S. degree from Case Western Reserve University and a M.B.A. degree from the University of Chicago Graduate School of Business. |
| Brown, Thomas | Thomas D. Brown has served as a Director of Stericycle Inc., since May 2008. From 1974 until his retirement in 2002, Mr. Brown held various sales, marketing and management positions at Abbott Laboratories, a diversified health care company, where he served as a senior vice president and the president of the diagnostics division from 1998 to 2002 and as corporate vice president for worldwide commercial operations from 1993 to 1998. He is a director of Quidel Corporation, a developer and manufacturer of point-of-care diagnostic tests, and Cepheid, a molecular diagnostics company. Mr. Brown received a B.A. degree from the State University of New York at Buffalo. |
| Reid-Anderson, James | Mr. James Reid-Anderson serves as Director of Stericycle, Inc since November, 2009. He is a healthcare adviser to the managing board of Siemens AG, a worldwide manufacturer and supplier of electronics and electrical engineering in the industrial, energy and healthcare sectors. From May through November 2008 he was a member of Siemens AG’s managing board and chief executive officer of Siemens Healthcare Sector, and from November 2007 through April 2008 he was the chief executive officer of Siemens Healthcare Diagnostics. From September 2000 to November 2007 Mr. Reid-Anderson served as chairman of the board, president and chief executive officer of Dade Behring Holdings, Inc., which he joined in August 1986. Mr. Reid-Anderson is a fellow of the Association of Chartered Certified Accountants and received a BCom (Hons) commerce degree from the University of Birmingham (in the United Kingdom). |
Basic Compensation
| Name | Fiscal Year Total |
|---|---|
| Miller, Mark | 2,297,440 |
| Ten Brink, Frank | 1,034,240 |
| Collins, Michael | 1,050,320 |
| Kogler, Richard | 1,064,100 |
| Foss, Richard | 974,739 |
| Marasco, Richard | -- |
| Schuler, Jack | -- |
| Dammeyer, Rod | -- |
| Patience, John | -- |
| Lord, Jonathan | -- |
| Hall, William | -- |
| Spaeth, Ronald | -- |
| Brown, Thomas | -- |
| Reid-Anderson, James | -- |
As Of 30 Dec 2008
Options Compensation
| Name | Options | Value |
|---|---|---|
| Miller, Mark | 854,595 | 11,199,340 |
| Ten Brink, Frank | 233,820 | 7,046,040 |
| Collins, Michael | 0 | 0 |
| Kogler, Richard | 100,276 | 2,158,927 |
| Foss, Richard | 93,087 | 1,401,217 |
| Marasco, Richard | 0 | 0 |
| Schuler, Jack | 0 | 0 |
| Dammeyer, Rod | 0 | 0 |
| Patience, John | 0 | 0 |
| Lord, Jonathan | 0 | 0 |
| Hall, William | 0 | 0 |
| Spaeth, Ronald | 0 | 0 |
| Brown, Thomas | 0 | 0 |
| Reid-Anderson, James | 0 | 0 |
| Name | Shares Traded | Price |
|---|---|---|
| DAMMEYER RODNEY F | 270 | $55.66 |
| DAMMEYER RODNEY F | 90 | $55.66 |
| TEN BRINK FRANK JM | 4,094 | $55.70 |
| COLLINS MICHAEL J | 6,152 | $32.21 |
| TEN BRINK FRANK JM | 10,000 | $55.70 |
| COLLINS MICHAEL J | 42,061 | $55.55 |
| COLLINS MICHAEL J | 42,061 | $32.21 |
| TEN BRINK FRANK JM | 18,307 | $55.52 |
| TEN BRINK FRANK JM | 41,000 | $56.38 |
| TEN BRINK FRANK JM | 24,048 | $7.60 |
| TEN BRINK FRANK JM | 12,734 | $56.06 |
| TEN BRINK FRANK JM | 26,288 | $5.06 |
| TEN BRINK FRANK JM | 21,812 | $17.53 |
| COLLINS MICHAEL J | 1,387 | $56.57 |
| COLLINS MICHAEL J | 1,387 | $32.21 |
| MILLER MARK C | 27,576 | $57.47 |
| MILLER MARK C | 122,052 | $13.69 |
| MILLER MARK C | 1,462 | $57.62 |
| MILLER MARK C | 13,524 | $57.62 |
| MILLER MARK C | 2,526 | $17.53 |
| MILLER MARK C | 3,814 | $57.62 |
| MILLER MARK C | 14,952 | $13.69 |
| MILLER MARK C | 95,100 | $57.93 |
| MILLER MARK C | 65,702 | $57.62 |
| MILLER MARK C | 23,804 | $16.53 |





